| Literature DB >> 33285682 |
Li-Jun Chen1, Yue-Dong Han1, Ming Zhang2.
Abstract
Insulinoma is the most common functional neuroendocrine tumor that originates from the islet of beta cells. Insulinoma is usually an isolated benign tumor and small in size (<2 cm). Due to the small size of the lesion, it often leads to difficulty in clinical preoperative localization diagnosis. However, we have unexpectedly discovered that the diffusion-weighted-imaging (DWI) adds great value in the preoperative localization diagnosis of insulinoma in non-invasive examination technique.We verified using operative pathology data and retrospectively analyzed the clinical and imageology findings of 5 cases who reported to have an insulinoma. All the 5 cases underwent DWI examination, among non-contrast enhanced magnetic resonance imaging (MRI) in 1 case, contrast-enhanced MRI in 4 cases.Five cases of DWI showed a nodular high signal <1.3 cm with pancreatic tail in 3 cases, pancreatic neck, and pancreatic head in 1 case each, respectively. Non-contrast enhanced MRI showed suspicious abnormal signals in the tail of the pancreas were detected in 1 case. MRI enhanced scans presented 2 cases with abnormal enhancement in the arterial phase and 2 cases without abnormal enhancement in arterial phase. Also, 3 cases showed mild persistence enhanced in the portal venous phase and delayed phase. However, 1 case remained normal in the portal venous phase and the delay period.DWI examination has high clinical value in the localization diagnosis of insulinoma and thus it can be used as a routine examination for preoperative localization diagnosis.Entities:
Mesh:
Year: 2020 PMID: 33285682 PMCID: PMC7717785 DOI: 10.1097/MD.0000000000023048
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Demographic and clinical characteristics of patients with insulinoma.
| Baseline parameter | Variable patients (n = 5) |
| Age, Median (IQR) 47 (44–54) | |
| Gender, n (%) | |
| Male | 3 (60) |
| Female | 2 (40) |
| Median (IQR) | |
| Hypoglycemic symptoms, n (%) | |
| Fasting hypoglycemia | 3 (60) |
| After meal hypoglycemia | 2 (40) |
| Syncopes | 4 (80) |
| Seizures | 2 (40) |
| Confusion | 1 (20) |
| Fasting hypoglycemia | |
| Glycemia (mmol/L) Mean (SD) | 1.3–1.9 (0.24) |
| Plasma insulin (ng/mL) | 8.5–18.6 (4.26) |
| Serum C peptide (ng/mL) | 7.8–10.9 (1.27) |
| After meal hypoglycemia | |
| Glycemia (mmol/L) Mean (SD) | 1.45–1.65 (0.1) |
| Plasma insulin (ng/mL) | 6.63–7.51 (0.44) |
| Serum C peptide (ng/mL) | 2.0–3.8 (0.9) |
Figure 1Male, 44 years. a Axial T1-weighted images fat suppression sequence, there is a slightly lower signal nodule can be seen in the tail of the pancreas, b contrast-enhanced magnetic resonance imaging arterial later phase, no significant contrast enhancement in lesions, c contrast-enhanced magnetic resonance imaging portal vein phase, there is a mild enhancement in lesions, d diffusion-weighted imaging black-and-white reversal view showed a nodular low signal in the tail of the pancreas, with a diameter of about 1.3 cm.
Figure 5Male, 48 years. a Axial contrast-enhanced magnetic resonance imaging arterial early phase, there is a significant enhancement lesions in pancreatic head, b axial contrast-enhanced magnetic resonance imaging arterial delay phase. Mild delayed enhancement of lesions, c diffusion-weighted imaging showed a slightly higher signal in the head of the pancreas, with a diameter of about 0.8 cm, d diffusion-weighted imaging black-and-white reversal view showed a nodular low signal in the head of the pancreas.
Examination and surgical results.
| Localization of the tumorn (%) | |
| Tail | 3 (60) |
| Head | 1 (20) |
| Neck | 1 (20) |
| Diameter of the lesionMean (SD) | 0.6–1.3cm (0.94 ± 0.24) |
| Detection of lesions | |
| DWI | 5 |
| Non-enhanced MRI | 1 |
| Enhanced MRI | 4 |
| Surgical removal | 5 |
| Postoperative complications 3 cases | |
| Pancreatic fistula 2cases | |
| Follow-up6 mo∼1 yr |
DWI = diffusion-weighted-imaging, MRI = magnetic resonance imaging, SD = Standard deviation.